By writer to www.globenewswire.com
Quanta to Host Knowledgeable Views Webinar on House Dialysis
Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Applied sciences Ltd (“Quanta” or the “Firm”), a British medical expertise innovation firm, as we speak publicizes that it will likely be internet hosting an Knowledgeable Views Webinar on residence dialysis on Monday 21 September at 4pm BST / 11am EDT.
The webinar will characteristic displays by Key Opinion Leaders, Dr. Sandip Mitra (Manchester College NHS Basis Belief), Veronika Dubajova (Senior European Medtech Analyst at Goldman Sachs), Dr. Ian Rechner (Intensive Care Medication Guide, Royal Berkshire NHS Basis Belief) and Affected person Advocate and House Dialysis Affected person, Maddy Warren, who will focus on a variety of subjects targeted on residence dialysis. The presentation might be adopted by a stay moderated Q&A with the panel and viewers by Tina Tan, Govt Editor at FirstWord MedTech.
The administration workforce at Quanta Dialysis Applied sciences may also be out there to debate SC+, its small, easy and versatile haemodialysis system. SC+ is commercially out there within the UK, the place it has been efficiently used to deal with sufferers throughout a variety of care settings, from the ICU and the clinic to the house. The Firm has submitted its 510(okay) with the FDA and is planning US business launch throughout 2021. The modern and patented expertise behind SC+ relies on a design breakthrough that allows all dialysate fluid administration to be carried out on a small, light-weight, disposable cartridge.
Featured Audio system and agenda:
John E. Milad, Chief Govt Officer, Quanta Dialysis Applied sciences
Session 1 – Market views on residence dialysis
Veronika Dubajova, Senior European Medtech Analyst, Goldman Sachs
- Overview of the house dialysis market
- Traits and drivers of development in residence dialysis
Session 2 – Why ought to sufferers dialyse at residence
Dr. Sandip Mitra, Guide Nephrologist, Manchester College NHS Basis Belief
- Clinicians’ view of who can profit from residence dialysis
- What a clinician wants from a tool
Session 3 – The Govt Order
Dr. Paul Komenda, Chief Medical Officer, Quanta Dialysis Applied sciences
- How shortly will dialysis be adopted routinely in North America?
- The sensible implications of shifting many sufferers residence
Session 4 – Residing with dialysis
Maddy Warren, Affected person Advocate and House Dialysis Affected person
- The day after day expertise of a affected person dialysing
- The liberty that residence dialysis provides to a affected person
Session 5 – SC+ within the ICU
Dr. Ian Rechner, Intensive Care Medication Guide, Royal Berkshire NHS Basis Belief
- COVID-19 and the decision for extra dialysis machines
- Working in partnership with Quanta
Session 6 – Moderated panel and viewers Q&A
Tina Tan, Govt Editor at FirstWord MedTech
The Knowledgeable Views Webinar is scheduled to shut at 6pm BST / 1pm EDT
For extra details about Quanta, please contact:
About Quanta and SC+
Primarily based within the Midlands of the UK, Quanta is a technology-enabled supplier of modern dialysis services. Quanta goals to enhance dialysis experiences and assist folks to stay extra freely. The lead product SC+ is a small, easy and versatile haemodialysis system designed to offer better freedom and suppleness within the supply of life sustaining dialysis remedies — making the remedy manageable to a broad vary of customers throughout a variety of environments, from the ICU to the house.
SC+ is commercially out there within the UK, the place it has been efficiently used to deal with sufferers throughout a variety of care settings, from the ICU and the clinic to the house. The modern and patented expertise behind SC+ relies on a design breakthrough that enables all dialysate fluid administration to be carried out on a small, light-weight, disposable cartridge. The unobtrusive, simple-to-use and digitally related design of SC+ is meant to empower extra sufferers to take management of their lives with selfcare and residential dialysis. In the meantime, as a compact, transportable and versatile machine, SC+ supplies flexibility to ship dialysis throughout a variety of use environments and prescriptions.
For extra data, please go to our web site: quantadt.com
SC+ shouldn’t be but FDA cleared and never but out there on the market or use within the USA.